Citalopram for Agitation in Alzheimer's Disease

NCT00898807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Agitation

Interventions

DRUG: citalopram
DRUG: placebo

Sponsor

JHSPH Center for Clinical Trials

Collaborators

[object Object]
[object Object]